1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Obesity and cancer: Concepts and challenges
    Journal Article

    Argolo, D. F.; Iyengar, N. M.; Hudis, C. A.
    Indian Journal of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Menstruation Is an unreliable surrogate in the assessment of ovarian damage by chemotherapy: A prospective longitudinal study with AMH levels as the gold standard
    Meeting Abstract

    Bedoschi, G.; Goldfarb, S.; Quistorff, J.; Goswami, S.; Moy, F.; Dickler, M.; Oktay, K.
    Fertility and Sterility (2015)

    Fulltext@MSK | Save
  • Characterization of rectal cancer in patients with lynch syndrome
    Meeting Abstract

    Ng, S. Y.; Shia, J.; Cercek, A.; Segal, N.; Reidy, D.; Yaeger, R.; Nash, G.; Temple, L. K. F.; Weiser, M.; Kelsen, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Neoadjuvant therapy in breast cancer as a casis for drug approval
    Journal Article

    Berry, D. A.; Hudis, C. A.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Genetic heterogeneity and distinct driver mutations in synchronous primary and metastatic breast cancers from therapy-naive patients
    Meeting Abstract

    Ng, C. K. Y.; Bidard, F. C.; Piscuoglio, S.; Lim, R. S.; Pierga, J. Y.; Cottu, P.; Vincent-Salomon, A.; Viale, A.; Norton, L.; Sigal, B.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Homology-directed repair in mouse mammary tissue
    Meeting Abstract

    Kass, E.; Moynahan, M. E.; Jasin, M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase II trial of exemestane and ruxolitinib for aI-resistant ER plus breast cancer: Interim safety, efficacy, and biomarker analysis
    Meeting Abstract

    DeMichelel, A. M.; Colameco, C. B.; Kalota, A.; Troxel, A. B.; Holmes, R.; Cimildoro, R.; Zafman, K.; Fox, K. R.; Domchek, S. M.; Gogineni, K.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save